CN
EN
Serch
About
Back
About YolTech
Leadership
Advisory Board
Investors
Science & Pipeline
Back
Pipeline
Genome Editing Platform
LNP Delivery Platform
Patients and Caregivers
Back
Clinical Study
Disease
Expanded Access Policy
News
Back
Press Release
Events & Presentation
Publication
Career
Back
Corporate Culture
Job Opportunites
Contact Us
Back
contact
CN
CN
EN
About
Science & Pipeline
Patients and Caregivers
News
Career
Contact Us
About YolTech
Leadership
Advisory Board
Investors
Pipeline
Genome Editing Platform
LNP Delivery Platform
Clinical Study
Disease
Expanded Access Policy
Press Release
Events & Presentation
Publication
Corporate Culture
Job Opportunites
contact
PRESS RELEASE
Home
News
Press Release
Press Release
Events & Presentation
Publication
Search
2026
2025
2024
2023
Dec 14, 2023
First Patient Dosed in Clinical Trial of YOLT-201 for ATTR-CM
Read More
Dec 06, 2023
YolTech Announces NMPA Acceptance of IND Application for YOLT-201 to Treat hATTR
Read More
Dec 01, 2023
YolTech Secured $15 Million in Series A+ Financing
Read More
1
2
3
4
5
6
7
8
Prev
